Who are anti spasmodic agents's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Ileocolonic release peppermint oil, Phloroglucin(Flospan®).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/anti-spasmodic-agents.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

anti spasmodic agents — Competitive Intelligence Brief

anti spasmodic agents (anti spasmodic agents) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antispasmodic agent. Area: Gastroenterology.

marketed Antispasmodic agent Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

anti spasmodic agents (anti spasmodic agents) — Laboratoires Mayoly Spindler. Antispasmodic agents reduce muscle contractions and spasms by inhibiting smooth muscle contraction in the gastrointestinal tract and other organs.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
anti spasmodic agents TARGET	anti spasmodic agents	Laboratoires Mayoly Spindler	marketed	Antispasmodic agent
Ileocolonic release peppermint oil	Ileocolonic release peppermint oil	Maastricht University Medical Center	phase 3	Herbal antispasmodic agent
Phloroglucin(Flospan®)	Phloroglucin(Flospan®)	Keimyung University Dongsan Medical Center	phase 3	Antispasmodic agent	Phosphodiesterase; calcium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antispasmodic agent class)

Keimyung University Dongsan Medical Center · 1 drug in this class
Laboratoires Mayoly Spindler · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). anti spasmodic agents — Competitive Intelligence Brief. https://druglandscape.com/ci/anti-spasmodic-agents. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab